Related Experiment Video

Updated: Aug 11, 2026

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells
08:11

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells

Published on: August 7, 2021

Effects of MdmX on Mdm2-mediated downregulation of pRB

Chiharu Uchida1, Seiichi Miwa, Tomoyasu Isobe

  • 1Department of Biochemistry 1, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka 431-3192, Japan.

FEBS Letters
|March 3, 2006
PubMed

Insights

MdmX inhibits Mdm2-mediated ubiquitination of the retinoblastoma tumor suppressor protein (pRB), unlike its known role in p53 degradation. This suggests MdmX has distinct regulatory functions in cancer pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Mdm2 is an oncogenic ubiquitin ligase overexpressed in cancers, promoting tumor suppressor p53 ubiquitination and degradation.
  • Mdm2 also degrades the retinoblastoma tumor suppressor protein (pRB) through the ubiquitin-proteasome system.
  • MdmX, a homolog of Mdm2, enhances Mdm2-mediated p53 ubiquitination and degradation, negatively regulating p53 function.

Purpose of the Study:

  • To investigate the effect of MdmX on Mdm2-mediated ubiquitination of pRB.
  • To determine if MdmX has a similar role in regulating pRB as it does for p53.

Main Methods:

  • Cellular assays were used to assess Mdm2-mediated pRB ubiquitination in the presence of MdmX.
  • Small interfering RNA (siRNA) was employed to reduce endogenous MdmX levels.
  • Overexpression of MdmX was utilized to study its effects on pRB levels and function.

Main Results:

  • MdmX significantly inhibited Mdm2-mediated pRB ubiquitination.
  • Knockdown of MdmX using siRNA led to a decrease in endogenous pRB levels.
  • Overexpression of MdmX resulted in stimulated pRB functions in cultured cells.

Conclusions:

  • MdmX exhibits differential regulation of Mdm2 activity towards pRB and p53.
  • MdmX may play a distinct role in controlling pRB stability and function compared to its role in p53 regulation.
  • These findings highlight a complex regulatory network involving Mdm2, MdmX, p53, and pRB in cancer.

More Related Videos

Inducible and Reversible Dominant-negative (DN) Protein Inhibition08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...